[Chemotherapeutic action of quinozaline derivatives and N-oxides of quinoxaline in acute bacterial infections].
D000208:Acute Disease; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D002701:Chloramphenicol / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000627:therapeutic use*; D003015:Clostridium Infections / Q000188:drug therapy; D003497:Cyclic N-Oxides / Q000627:therapeutic use*; D004165:Diphtheria / Q000188:drug therapy; D004405:Dysentery, Bacillary / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D007239:Infections / Q000188:drug therapy*; D007710:Klebsiella Infections / Q000188:drug therapy; D051379:Mice; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011810:Quinoxalines / Q000627:therapeutic use*; D012481:Salmonella Infections, Animal / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D003497:Cyclic N-Oxides; D011810:Quinoxalines; D002701:Chloramphenicol; D002751:Chlortetracycline
Khimioterapevticheskaia aktivnost' proizvodnykh khinoksalina i N-okiseĭ khinoksalina pri ostrykh bakterial'nykh infektsiiakh.